International Headache Society (@ihs_official) header
International Headache Society (@ihs_official) profile picture

To advance headache science, education & treatment. Our Journal: @JCephalalgia. Find us on https://teapawt.org/t.co/wjNPoTFjTr…

London, United Kingdom
Joined November 2014
Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)Photo by International Headache Society (@ihs_official)
New in Cephalalgia Reports! CAPTURE will provide greatly needed international longitudinal data assessing determinants of the evolution of migraine and its associated burden in the context of contemporary treatment patterns. These results will enhance our understanding of predictors of the course of migraine over time. A clinical algorithm tool utilizing artificial intelligence machine learning will be applied to identify potential predictors of migraine evolution and guide individualized treatment. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
118
New in Cephalalgia Reports! Migraine screening-positive prevalence was 22.4% across 3,317 adults from Arab countries. Migraine showed independent associations with IBS and GERD, plus modifiable lifestyle risks. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
1
4
258
We are delighted to share that Professor Simona Sacco, Editor-in-Chief of Cephalalgia and Cephalalgia Reports, has been named among the 2026 Highly Cited Researchers by Clarivate. This prestigious international recognition acknowledges researchers whose work has demonstrated significant and sustained influence within their fields, reflecting the reach and impact of their scientific contributions. For the Cephalalgia community, this is also an opportunity to celebrate the importance of high-quality research in advancing our understanding of headache disorders and improving the lives of people living with these conditions. We are proud to have Professor Sacco @Simona_Sacco_ leading Cephalalgia and Cephalalgia Reports and contributing to the development of our international scientific community. Congratulations, Simona! 🔗 Discover the 2026 Highly Cited Researchers: clarivate.com/highly-cited-r… #Cephalalgia #HighlyCitedResearchers #Clarivate #HeadacheResearch #Migraine #ScientificExcellence
1
135
New in Cephalalgia Reports! Migraine subtyping based on naturalistic and comprehensive phenotype assessment Two migraine subgroups were identified: one with greater disability and psychiatric conditions, and another with higher self-efficacy and better treatment response. Depression, anxiety, and disability were the main distinguishing factors. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
126
New in Cephalalgia Reports! Educational interventions may improve headache outcomes, disability, quality of life, self-efficacy, medication use, and adherence. • Evidence is strongest for migraine and MOH but remains limited for other headache disorders and often comes from multicomponent interventions. • Migraine education should be concise, individualized, reinforced over time, and focused on diagnosis, lifestyle, medication, complication recognition, and follow-up according to individual patient needs. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
1
5
248
New in Cephalalgia! Migraine is chronic. Its frequency varies. This latest correspondence argues that it may be time to reconsider the terms “episodic” and “chronic” migraine and adopt terminology that better reflects migraine as a spectrum disorder. What do you think? What terms do you suggest? journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
4
1
9
404
New in Cephalalgia! A definition of restlessness that includes both its observable and its subjective dimensions would bring us closer to capturing the full clinical phenotype of cluster headache and, ultimately, to shortening the diagnostic delay for patients who do not fit the textbook picture. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
1
1
2
217
New in Cephalalgia! In cluster headache, some patients who lie down roll or rock. Asking “When you lie down during an attack, can you actually remain still?” may identify overlooked restlessness/agitation in those who took longer to recognize they had CH. journals.sagepub.com/doi/10.… #ClusterHeadache #ICHD3matters #IHS
171
Did you know that headache attributed to IIH has no specific clinical phenotype? It can closely resemble chronic migraine or chronic tension-type headache. Moreover, primary headache disorders may coexist with IIH. The ICHD-3 criteria require: - A new headache or significant worsening of a pre-existing headache. - Confirmed IIH and elevated CSF pressure. - Evidence supporting a temporal or clinical relationship between IIH and headache. - No better alternative ICHD-3 diagnosis. An important clinical consideration: IIH should be diagnosed with caution in patients without papilloedema. In these cases, alternative explanations, including medication-overuse headache, must be carefully considered. **The key message:** identifying IIH is not simply about recognizing a headache pattern. It requires integrating clinical findings, ophthalmological assessment, neuroimaging and CSF pressure measurements. #Migraine #HeadacheDisorders #ichd3matters
4
14
691
New in Cephalalgia! • Long-term treatment of atogepant for the preventive treatment of migraine was safe and well tolerated. Overall safety results across 156 weeks were consistent with the known safety profile of atogepant; no new safety signals were observed. • Efficacy and functional outcomes showed improvement from lead-in study baseline at weeks 13–16 and were consistent through 156 weeks. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
4
7
369
New in Cephalalgia! In this real-world case series, gepants were associated with clinically meaningful reductions in attack frequency in patients with active cluster headache bouts, with good short-term tolerability. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
2
4
392
New in Cephalalgia! Atogepant showed rapid reductions in headache burden within one week in episodic cluster headache. Improvements across outcomes support its potential as an early preventive option in real-world practice. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
164
New in Cephalalgia! Management must move beyond reducing attack frequency to standardizing measures that capture and treat the full spectrum of pain-free disability. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
1
3
7
407
New in Cephalalgia! Rimegepant provides 2-hour pain freedom in nearly half of treated migraine attacks, with a consistent response across repeated attacks in a meaningful proportion of individuals. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
152
New in Cephalalgia! Post-hoc analyses in 234 women with suspected/confirmed hypertensive disorders of pregnancy (HDP) showed no association between migraine and sFlt-1, PlGF, or their ratio within HDP groups, yet differences were seen in the overall population journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
156
📣 Deadline extended: Complimentary registrations for IHS members! The ACEFAPERU Headache Summit 2026 will take place online on 26–28 November 2026. ACEFAPERU is offering complimentary registrations to IHS members, allocated on a first-come, first-served basis, with priority given to junior members. 📅 Extended application deadline: 20 November 2026 📧 To apply, email: [email protected] To learn more, please go to: ihs-headache.org/en/events/a…
2
5
289
New in Cephalalgia! A 10-year study developed and externally validated the Migraine Risk Stratification Score (MRSS) to stratify cryptogenic ischemic stroke (CIS) risk in patients with migraine and right-to-left shunt, with particular value for identifying individuals at low risk. journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
1
214
New in Cephalalgia! Across all countries, substantial humanistic and economic burden was reported in individuals with migraine and comorbid depression compared with individuals with migraine alone, emphasizing the need for comprehensive management and preventive strategies to cohesively address both conditions journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
2
140
New in Cephalalgia Reports! 🧠 How much can we learn about a headache simply by asking the right questions? When it comes to headache disorders, a good clinical history is often our most powerful diagnostic tool. But effective history-taking is more than ticking boxes. It requires active listening, empathy, structured questioning, and clinical reasoning. 📢 A new article published in Cephalalgia Reports by the International Headache Society Education Committee presents a practical approach to optimising headache history-taking: 1️⃣ Listen and connect: Build rapport, ask open-ended questions, and understand the patient's experience. 2️⃣ Characterise the headache: Explore the onset, timing, pain characteristics, associated symptoms, triggers, and impact on daily life. 3️⃣ Check for red flags: Identify warning signs of secondary headaches using tools such as SNNOOP10 and careful assessment of temporal patterns. 4️⃣ Explain and plan: Communicate the diagnosis, address patient concerns, and develop a shared management plan. 💡 The key message? Headache diagnosis is not just about recognising symptoms. It is about understanding the person experiencing them. And while digital tools and AI may support clinical assessment, they cannot replace the art of listening. 📖 Read the full paper: Souza MNP, et al. Optimizing headache history-taking: A structured approach from the International Headache Society Education Committee. Cephalalgia Reports. 2026;9. 🔗 doi.org/10.1177/251581632614… 💬 For clinicians: What is the one question you never forget to ask when taking a headache history? #CephalalgiaReports #HeadacheMedicine #Migraine #Neurology #HeadacheEducation #InternationalHeadacheSociety #MedicalEducation
1
133
New in Cephalalgia! Some other headache was unaccounted for in these studies; moreover, it was common: the Turkish study, with 7,088 participants, estimated its 1-year prevalence as 29.2%.6 The study authors labelled it “undifferentiated headache” (UdH) (in terminological alignment with A3.6 Undifferentiated trigeminal autonomic cephalalgia in ICHD-3). journals.sagepub.com/doi/10.… #migraine #headache #brain #pain #neurology #neuroscience
3
270